These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8222478)

  • 21. Pharmacokinetics and residues of ciprofloxacin and its metabolites in broiler chickens.
    Anadón A; Martínez-Larrañaga MR; Iturbe J; Martínez MA; Díaz MJ; Frejo MT; Martínez M
    Res Vet Sci; 2001 Oct; 71(2):101-9. PubMed ID: 11883887
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Obesity, sex, and acetaminophen disposition.
    Abernethy DR; Divoll M; Greenblatt DJ; Ameer B
    Clin Pharmacol Ther; 1982 Jun; 31(6):783-90. PubMed ID: 7075126
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lithium pharmacokinetics in the obese.
    Reiss RA; Haas CE; Karki SD; Gumbiner B; Welle SL; Carson SW
    Clin Pharmacol Ther; 1994 Apr; 55(4):392-8. PubMed ID: 8162665
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disposition kinetics of difloxacin after intravenous, intramuscular and subcutaneous administration in calves.
    ismail M
    Vet Res Commun; 2007 May; 31(4):467-76. PubMed ID: 17216308
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comprehensive model for enrofloxacin to ciprofloxacin transformation and disposition in dog.
    Cester CC; Toutain PL
    J Pharm Sci; 1997 Oct; 86(10):1148-55. PubMed ID: 9344173
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cefotiam disposition in markedly obese athlete patients, Japanese sumo wrestlers.
    Chiba K; Tsuchiya M; Kato J; Ochi K; Kawa Z; Ishizaki T
    Antimicrob Agents Chemother; 1989 Aug; 33(8):1188-92. PubMed ID: 2802548
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of cardiopulmonary bypass surgery on intravenous ciprofloxacin disposition.
    Pryka RD; Rodvold KA; Ting W; Levitsky S; Frost RW; Lettieri JT
    Antimicrob Agents Chemother; 1993 Oct; 37(10):2106-11. PubMed ID: 8257131
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Capillary electrophoresis with laser-induced fluorescence detection, an adequate alternative to high-performance liquid chromatography, for the determination of ciprofloxacin and its metabolite desethyleneciprofloxacin in human plasma.
    Bannefeld KH; Stass H; Blaschke G
    J Chromatogr B Biomed Sci Appl; 1997 May; 692(2):453-9. PubMed ID: 9188836
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lidocaine disposition in obesity.
    Abernethy DR; Greenblatt DJ
    Am J Cardiol; 1984 Apr; 53(8):1183-6. PubMed ID: 6702701
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of intravenous bisoprolol in obese and non-obese volunteers.
    Le Jeunne C; Poirier JM; Cheymol G; Ertzbischoff O; Engel F; Hugues FC
    Eur J Clin Pharmacol; 1991; 41(2):171-4. PubMed ID: 1683835
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of probenecid on the distribution and elimination of ciprofloxacin in humans.
    Jaehde U; Sörgel F; Reiter A; Sigl G; Naber KG; Schunack W
    Clin Pharmacol Ther; 1995 Nov; 58(5):532-41. PubMed ID: 7586947
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of enrofloxacin in Korean catfish (Silurus asotus).
    Kim MS; Lim JH; Park BK; Hwang YH; Yun HI
    J Vet Pharmacol Ther; 2006 Oct; 29(5):397-402. PubMed ID: 16958784
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Allometric analysis of ciprofloxacin and enrofloxacin pharmacokinetics across species.
    Cox SK; Cottrell MB; Smith L; Papich MG; Frazier DL; Bartges J
    J Vet Pharmacol Ther; 2004 Jun; 27(3):139-46. PubMed ID: 15189299
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Obesity effects on nitrazepam disposition.
    Abernethy DR; Greenblatt DJ; Locniskar A; Ochs HR; Harmatz JS; Shader RI
    Br J Clin Pharmacol; 1986 Nov; 22(5):551-7. PubMed ID: 3790401
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disposition kinetics and urinary excretion of ciprofloxacin in goats following single intravenous administration.
    Raina R; Prawez S; Dimitrova DJ; Pankaj NK; Verma PK
    J Vet Sci; 2008 Sep; 9(3):241-5. PubMed ID: 18716443
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics and milk penetration of difloxacin after intravenous, subcutaneous and intramuscular administration to lactating goats.
    Marín P; Escudero E; Fernández-Varón E; Cárceles CM
    J Vet Pharmacol Ther; 2007 Feb; 30(1):74-9. PubMed ID: 17217405
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dose ranging study and constant infusion evaluation of ciprofloxacin.
    Drusano GL; Plaisance KI; Forrest A; Standiford HC
    Antimicrob Agents Chemother; 1986 Sep; 30(3):440-3. PubMed ID: 3777907
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of ciprofloxacin in the elderly.
    Bayer A; Gajewska A; Stephens M; Stark JM; Pathy J
    Respiration; 1987; 51(4):292-5. PubMed ID: 3659579
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Caffeine disposition in obesity.
    Abernethy DR; Todd EL; Schwartz JB
    Br J Clin Pharmacol; 1985 Jul; 20(1):61-6. PubMed ID: 4027137
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin in goats given enrofloxacin alone and in combination with probenecid.
    Rao GS; Ramesh S; Ahmad AH; Tripathi HC; Sharma LD; Malik JK
    Vet J; 2002 Jan; 163(1):85-93. PubMed ID: 11749141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.